Impact of the shared decision-making process on lung cancer screening decisions

Background: Professional organizations recommend the use of shared decision-making (SDM) in supporting patients’ decisions about lung cancer screening (LCS). The objective of this study was to assess the impact of the SDM process on patient knowledge about LCS, decisional conflict, intentions to adh...

Full description

Bibliographic Details
Main Authors: Crocker, L.C (Author), Lopez-Olivo, M.A (Author), Lowenstein, L.M (Author), Mendoza, T.R (Author), Nishi, S.P.E (Author), Sepucha, K.R (Author), Tan, N.Q.P (Author), Volk, R.J (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02504nam a2200289Ia 4500
001 10-1002-cam4-4445
008 220420s2022 CNT 000 0 und d
020 |a 20457634 (ISSN) 
245 1 0 |a Impact of the shared decision-making process on lung cancer screening decisions 
260 0 |b John Wiley and Sons Inc  |c 2022 
300 |a 8 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/cam4.4445 
520 3 |a Background: Professional organizations recommend the use of shared decision-making (SDM) in supporting patients’ decisions about lung cancer screening (LCS). The objective of this study was to assess the impact of the SDM process on patient knowledge about LCS, decisional conflict, intentions to adhere to screening recommendations, and its role in how the patient made the final decision. Methods: This study surveyed patients screened for lung cancer within 12 months of the survey, recruited from two academic tertiary care centers in the South Central Region of the U.S. (May to July 2018). Results: Two hundred and sixty-four patients completed the survey (87.9% White, 52% male, and mean age of 64.81). Higher SDM process scores (which indicates a better SDM process reported by patients) were significantly associated with greater knowledge of LCS (b = 0.17 p < 0.01). Higher SDM process scores were associated with less decisional conflict about their screening choice (b = 0.45, p < 0.001), greater intentions to make the same decision again (OR = 1.42, 95% CI = [1.06–1.89]), and greater intentions to undergo LCS again (OR = 1.32, 95% CI = [1.08–1.62]). The SDM process score was not associated with patients’ report of whether or not they shared the final decision with the healthcare provider (OR = 1.07, 95% CI = [0.85–1.35]). Conclusion(s): This study found that a better SDM process was associated with better affective-cognitive outcomes among patients screened for lung cancer. © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. 
650 0 4 |a cancer screening 
650 0 4 |a decision aids 
650 0 4 |a decision making, shared 
650 0 4 |a implementation science 
650 0 4 |a lung cancer 
700 1 0 |a Crocker, L.C.  |e author 
700 1 0 |a Lopez-Olivo, M.A.  |e author 
700 1 0 |a Lowenstein, L.M.  |e author 
700 1 0 |a Mendoza, T.R.  |e author 
700 1 0 |a Nishi, S.P.E.  |e author 
700 1 0 |a Sepucha, K.R.  |e author 
700 1 0 |a Tan, N.Q.P.  |e author 
700 1 0 |a Volk, R.J.  |e author 
773 |t Cancer Medicine